Incipient CataractNCT02561104
Resident-Performed Laser-Assisted vs Manual Traditional Phacoemulsification Cataract Surgery
A study testing Laser-assisted cataract surgery. and Traditional manual phacoemulsification in people with Incipient Cataract and Senile Nuclear Sclerosis, run by University of Texas Southwestern Medical Center at 1 site in United States.
Trial summary
The study design will be a prospective study comparing laser-assisted cataract extraction cases and traditional manual phacoemulsification cases. All cases will be performed by faculty-supervised residents at Parkland Memorial Hospital. Read more about this study
- Who is it for?
- Ages 21 to 99 years
- Conditions the study is for
- Incipient Cataract, Senile Nuclear Sclerosis
- What is being tested?
- Laser-assisted cataract surgery. and Traditional manual phacoemulsification
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 148 participants
- Where
- 1 siteUnited States
- Study dates
- Dec 2015to 19 Jun 2018
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 to 99 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Referred for cataract surgery at Parkland Memorial Hospital
- Potential post-operative visual acuity of 20/30 or greater determined by potential acuity meter (PAM) testing or modified super pinhole potential acuity of 20/30 or greater
- Clear intraocular media other than cataract in study eye(s)
- Subject eyes will have a dilated pupil diameter of at least 6 mm
- Subject eyes will lack other pre-existing ocular pathology or condition that may confound treatment effects, including diabetic retinopathy, previous retinal detachment, iris neovascularization, amblyopia, optic nerve atrophy or recurrent severe anterior or posterior segment inflammation of unknown etiology.
Who cannot join
- Severe corneal diseases or prior corneal surgery
- Active, significant external ocular or eyelid disease
- History of lens abnormalities including posterior polar cataract and zonular weakness precluding standard non-complex cataract surgery
- Retinal or posterior segment disease
- Advanced glaucoma, white or advanced cataract (precluding adequate examination of the posterior pole)
- Anatomic conditions that prevent placement of the femtosecond laser docking ring
Show all 13Show fewer
- Corneal opacity that will interfere with the laser beam (hazy cornea)
- Presence of blood or materials in the anterior chamber
- Hypotony, advanced glaucoma, or presence of cornea implant
- Poor dilating pupil such that the iris is not peripheral to the intended diameter for the capsulotomy
- Condition which would cause inadequate clearance between the intended capsulotomy depth and the corneal endothelium
- Any contraindication to cataract or kerato-refractive surgery
- Contact lens wearers must discontinue the use of contacts for an appropriate period of time to ensure that their corneas are stable before screening measurements are performed. For rigid gas permeable (RGP) lenses, it is at least 2-4 weeks before accurate imaging measurements can be performed. Study doctor will assess patient findings and determine how long RGP lens wear must be discontinued prior to surgery. For soft contact lenses, it is at least 3 days prior to study measurements.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Outcomes of Resident-Performed Laser-Assisted vs Manual Traditional Phacoemulsification
The study design will be a prospective study comparing laser-assisted cataract extraction cases and traditional manual phacoemulsification cases. All cases will be performed by faculty-supervised residents at Parkland Memorial Hospital. This study aims to examine visual acuity and complication rates in femtosecond laser-assisted cataract surgery compared to traditional manual phacoemulsification cataract surgery for the beginning surgeon. In addition, this study will assess the subjective novice surgeon experience and the patient experience in terms of expectations and results.
Read the detailed description
The study design will be a prospective study comparing laser-assisted cataract extraction cases and traditional manual phacoemulsification cases. All cases will be performed by faculty-supervised residents at Parkland Memorial Hospital. Cataract surgery training is a standard requirement of all ophthalmology residents who are part of this clinical study.
Each resident must be a post graduate year 4 (PGY-4) level resident before being asked to be a part of this clinical study. Typically, each resident will have completed approximately 30 cataract surgeries by their PGY-3 residency year of training. These traditional phacoemulsification require manual capsulorrhexis creation with which residents will have experience prior to study participation. Other critical manual surgical steps of traditional and femtosecond-laser assisted cataract surgery require similar surgical skill sets, thus residents should have surgical skills applicable to both techniques prior to study involvement.
In addition to performing 30 traditional phacoemulsification surgeries, residents also will have assisted with femtosecond laser-assisted cases during their PGY-3 training year training at the Dallas VA medical center and with staff at University of Texas (UT) Southwestern Medical Center during their cornea rotation. The femtosecond-assisted cases completed by each resident in the study at Parkland will be the Alcon Certification cases for each resident. Performing femtosecond-laser assisted cases at this level of training will provide objective insights into this new surgical technique in resident hands. Patients will not be subjected to any additional risk due to participation in this study as femtosecond laser Alcon Certification is already being performed by residents as part of their standard UT Southwestern ophthalmology training.
Patient eyes that meet the inclusion and exclusion criteria below will be randomly assigned to either the laser-assisted or the standard manual phacoemulsification group based. Following surgery, patients will return for post-operative visits at post-op day 1, post-op week 1, post-op month 1, and post-op month 3. Subjects will be followed in the Parkland Surgery Chief clinic. Subjects will not necessarily see the same study surgeon during each post-operative visit period. It should be noted this is the standard procedure as currently practiced in the Parkland ophthalmology clinic.
Verification of subject adherence to the post-operative follow-up visit schedule will be overseen by the PI throughout the course of the project. Weekly communication with sub-investigators will take place in order to review any outstanding concerns including recruitment effort, surgery schedules, and post-operative visit timelines. Arrangements for additional visits will also be reviewed and scheduled if medically necessary depending on individual patients' post-operative clinical course. Patients will be assigned to each group during the period of September 2015 through July 2016 and followed as part of the study for 3 months post-operatively.
Patients will be offered the same kerato-refractive procedures including manual limbal relaxing incisions or LenSx astigmatic keratotomy that would be offered to patients who are not part of this study. Patients will also be evaluated for benefit from advanced technology intraocular lenses (Toric for astigmatism and ReStor multifocal) that patients who are not part of the study would be offered. Offering advanced technology lenses or combined kerato-refractive procedures is not expected to influence the visual acuity study outcomes for patients in this study. Patient's clinical history, past medical history and ophthalmic medical notes (in particular pre-operative evaluation, operative, and post-operative follow up) will be reviewed. De-identified data points will be extracted for this project.
- Conditions
- Incipient Cataract, Senile Nuclear Sclerosis
- Being tested
- Laser-assisted cataract surgery., Traditional manual phacoemulsification
- Keywords
- cataract, phacoemulsification, laser-assisted surgery, femtosecond laser
- Medical subject headings
- Cataract
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Laser-assisted cataract surgery.Procedure or surgery
Traditional manual phacoemulsificationProcedure or surgery
| Study group | Role | What they receive |
|---|---|---|
| LenSx | Experimental | Laser-assisted cataract surgery performed using the LenSx femtosecond laser. Receives: Procedure: Laser-assisted cataract surgery. |
| Phaco | Experimental | Traditional manual phacoemulsification cataract surgery Receives: Procedure: Traditional manual phacoemulsification |
What is being measured
The primary outcome is the main question the study is designed to answer.
Complication rates
Complication and adverse event monitoring will occur at each visit: pre-operative, operative, post-op day 1, post-op day 7-14, post-op day 30-60 and 3 mos post-op
Measured: Operative visit to last post-op visit at 3 mos
Visual Acuity
Bilateral best spectacle corrected visual acuity
Measured: Change between baseline and 3 mos post-op.
Secondary outcomes (5)
Patient benefit perception
Patient perception of results assessed by questionnaire
Measured: Post-op day 1
Patient benefit perception
Patient perception of results assessed by questionnaire
Measured: Post-op day 30-60
Patient benefit perception
Patient perception of results assessed by questionnaire
Measured: 3 mos post-op
Corneal Endothelial Cell Count (ECC)
Specular micrography performed at baseline and post-op day 30-60 OR 3 month post-op* to measure change in ECC
*3 month ECC test will be done only if test was unable to be performed on post-op day 30-60 visit
Measured: Change from baseline to post-op day 30-60
Lens removal time
Comparison of time required for nuclear and cortex removal using the two techniques
Measured: Operative visit
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Sep 2015 (estimated)
- Study startDec 2015
- Primary completion19 Jun 2018
- Study completion19 Jun 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Incipient CataractStudies of the same condition, open and under way.
- More trials run by University of Texas Southwestern Medical CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 148 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Texas Southwestern Medical Center
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Brock Hansen, M.D., Principal investigator, University of Texas Southwestern Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02561104
- Sponsor's protocol ID
- STU 092014-020
- Status last verified
- May 2020
- First submitted
- 24 Sep 2015
- Last updated
- 21 May 2020
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 21 May 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Outcomes of Resident-Performed Laser-Assisted vs Manual Traditional Phacoemulsification
- ClinicalTrials.gov ID
- NCT02561104
- Acronym / sponsor ID
- STU 092014-020
- Conditions
- Incipient Cataract, Senile Nuclear Sclerosis
- Keywords
- cataract, phacoemulsification, laser-assisted surgery, femtosecond laser
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 148 participants (actual)
- Lead sponsor
- University of Texas Southwestern Medical CenterUniversity, hospital or other
- Study start
- Dec 2015 (actual)
- Primary completion
- 19 Jun 2018 (actual)
- Study completion
- 19 Jun 2018 (actual)
- First posted
- 25 Sep 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study design will be a prospective study comparing laser-assisted cataract extraction cases and traditional manual phacoemulsification cases. All cases will be performed by faculty-supervised residents at Parkland Memorial Hospital. This study aims to examine visual acuity and complication rates in femtosecond laser-assisted cataract surgery compared to traditional manual phacoemulsification cataract surgery for the beginning surgeon. In addition, this study will assess the subjective novice surgeon experience and the patient experience in terms of expectations and results.
Detailed description
The study design will be a prospective study comparing laser-assisted cataract extraction cases and traditional manual phacoemulsification cases. All cases will be performed by faculty-supervised residents at Parkland Memorial Hospital. Cataract surgery training is a standard requirement of all ophthalmology residents who are part of this clinical study.
Each resident must be a post graduate year 4 (PGY-4) level resident before being asked to be a part of this clinical study. Typically, each resident will have completed approximately 30 cataract surgeries by their PGY-3 residency year of training. These traditional phacoemulsification require manual capsulorrhexis creation with which residents will have experience prior to study participation. Other critical manual surgical steps of traditional and femtosecond-laser assisted cataract surgery require similar surgical skill sets, thus residents should have surgical skills applicable to both techniques prior to study involvement.
In addition to performing 30 traditional phacoemulsification surgeries, residents also will have assisted with femtosecond laser-assisted cases during their PGY-3 training year training at the Dallas VA medical center and with staff at University of Texas (UT) Southwestern Medical Center during their cornea rotation. The femtosecond-assisted cases completed by each resident in the study at Parkland will be the Alcon Certification cases for each resident. Performing femtosecond-laser assisted cases at this level of training will provide objective insights into this new surgical technique in resident hands. Patients will not be subjected to any additional risk due to participation in this study as femtosecond laser Alcon Certification is already being performed by residents as part of their standard UT Southwestern ophthalmology training.
Patient eyes that meet the inclusion and exclusion criteria below will be randomly assigned to either the laser-assisted or the standard manual phacoemulsification group based. Following surgery, patients will return for post-operative visits at post-op day 1, post-op week 1, post-op month 1, and post-op month 3. Subjects will be followed in the Parkland Surgery Chief clinic. Subjects will not necessarily see the same study surgeon during each post-operative visit period. It should be noted this is the standard procedure as currently practiced in the Parkland ophthalmology clinic.
Verification of subject adherence to the post-operative follow-up visit schedule will be overseen by the PI throughout the course of the project. Weekly communication with sub-investigators will take place in order to review any outstanding concerns including recruitment effort, surgery schedules, and post-operative visit timelines. Arrangements for additional visits will also be reviewed and scheduled if medically necessary depending on individual patients' post-operative clinical course. Patients will be assigned to each group during the period of September 2015 through July 2016 and followed as part of the study for 3 months post-operatively.
Patients will be offered the same kerato-refractive procedures including manual limbal relaxing incisions or LenSx astigmatic keratotomy that would be offered to patients who are not part of this study. Patients will also be evaluated for benefit from advanced technology intraocular lenses (Toric for astigmatism and ReStor multifocal) that patients who are not part of the study would be offered. Offering advanced technology lenses or combined kerato-refractive procedures is not expected to influence the visual acuity study outcomes for patients in this study. Patient's clinical history, past medical history and ophthalmic medical notes (in particular pre-operative evaluation, operative, and post-operative follow up) will be reviewed. De-identified data points will be extracted for this project.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| LenSx | Experimental | Procedure: Laser-assisted cataract surgery.Laser-assisted cataract surgery performed using the LenSx femtosecond laser. |
| Phaco | Experimental | Procedure: Traditional manual phacoemulsificationTraditional manual phacoemulsification cataract surgery |
Who may qualify
- Ages
- 21 to 99 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Referred for cataract surgery at Parkland Memorial Hospital
- Potential post-operative visual acuity of 20/30 or greater determined by potential acuity meter (PAM) testing or modified super pinhole potential acuity of 20/30 or greater
- Clear intraocular media other than cataract in study eye(s)
- Subject eyes will have a dilated pupil diameter of at least 6 mm
- Subject eyes will lack other pre-existing ocular pathology or condition that may confound treatment effects, including diabetic retinopathy, previous retinal detachment, iris neovascularization, amblyopia, optic nerve atrophy or recurrent severe anterior or posterior segment inflammation of unknown etiology.
Key exclusion criteria (13 listed)
- Severe corneal diseases or prior corneal surgery
- Active, significant external ocular or eyelid disease
- History of lens abnormalities including posterior polar cataract and zonular weakness precluding standard non-complex cataract surgery
- Retinal or posterior segment disease
- Advanced glaucoma, white or advanced cataract (precluding adequate examination of the posterior pole)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Laser-assisted cataract surgery. | Procedure or surgery | LenSx |
| Traditional manual phacoemulsification | Procedure or surgery | Phaco |
Primary outcome
Complication rates
Time frame: Operative visit to last post-op visit at 3 mos
Complication and adverse event monitoring will occur at each visit: pre-operative, operative, post-op day 1, post-op day 7-14, post-op day 30-60 and 3 mos post-op
Visual Acuity
Time frame: Change between baseline and 3 mos post-op.
Bilateral best spectacle corrected visual acuity
5 secondary outcomes
Patient benefit perception
Time frame: Post-op day 1
Patient benefit perception
Time frame: Post-op day 30-60
Patient benefit perception
Time frame: 3 mos post-op
Corneal Endothelial Cell Count (ECC)
Time frame: Change from baseline to post-op day 30-60
Lens removal time
Time frame: Operative visit
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 May 2020.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Brock Hansen, M.D. principal investigator
University of Texas Southwestern Medical Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Laser-assisted cataract surgery. and Traditional manual phacoemulsification in people with Incipient Cataract and Senile Nuclear Sclerosis, run by University of Texas Southwestern Medical Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 May 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Complication rates (time frame: Operative visit to last post-op visit at 3 mos). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 May 2020.